Evidence map›Paper›PMID 12085232›Full record

ArticleOncogene2002

Differential regulation of Rb family proteins and prohibitin during camptothecin-induced apoptosis.

Gina Fusaro, Sheng Wang, Srikumar Chellappan

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 106 citations in OpenAlex.

  1. Resistance of E2F4DN to p38Scientific reports · 2026
    Article
  2. Paraptosis-A Distinct Pathway to Cell Death.International journal of molecular sciences · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. A Putative Prohibitin-Calcium Nexus inJournal of diabetes research · 2020
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Multifaceted role of prohibitin in cell survival and apoptosis.Apoptosis : an international journal on programmed cell death · 2015
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Gina FusaroDepartment of Pathology, College of Physicians and Surgeons, Columbia University, 630 W 168th St, New York, NY 10032, USA.
Sheng Wang
Srikumar Chellappan
Columbia University · USMoffitt Cancer Center · US

Funding

PROHIBITION GENE IN GROWTH CONTROL AND TUMOR SUPPRESSIONR01CA077301 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI CHELLAPPAN, SRIKUMAR P. · 1999 to 2009
$2.0M
NCI NIH HHS CA77301
6 · The paper itself

Abstract

Prohibitin, a potential tumor suppressor, is known to induce growth suppression and repress E2F-mediated transcription. These growth regulatory functions of prohibitin require a physical interaction with the Rb protein. We now find that prohibitin protects cells from apoptosis mediated by camptothecin, a topoisomerase I inhibitor. Camptothecin treatment of Ramos B cells leads to the degradation of Rb protein and phosphorylation of its family members, p107 and p130. This correlates with an increase in the levels of cyclin E as well as the kinase activity associated with it. Inactivation of Rb leads to the dissociation and release of free E2F. We find also that E2F activity is induced upon camptothecin treatment, but this increase is absent in prohibitin overexpressing cells. It thus appears that prohibitin may be inhibiting apoptosis by downregulating E2F activity when Rb family members are inactive.

Indexed as

Cell Cycle ProteinsDNA-Binding ProteinsRepressor ProteinsApoptosisBlotting, WesternCamptothecinCell LineCyclin EE2F Transcription FactorsElectrophoretic Mobility Shift AssayGene Expression RegulationHumansProhibitinsProteinsRetinoblastoma ProteinRNA, MessengerCamptothecinCell Cycle ProteinsCyclin EDNA-Binding ProteinsE2F Transcription FactorsProhibitinsProteinsRepressor ProteinsRetinoblastoma ProteinRNA, MessengerTranscription Factors

Identifiers

PMID12085232
OpenAlexW2317477856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.